GlobeNewswire by notified

Solvay to hold 2022 Annual General Meeting

Share

Solvay to hold 2022 Annual General Meeting

Proposal to appoint two new independent directors to strengthen financial and governance expertise and enhance diversity

Brussels, April 8, 2022 - 8:30 CEST

Solvay today announced that it has published materials for its next Ordinary General Shareholders’ Meeting, which will be held on Tuesday May, 10, 2022 in Brussels, at 10.30 a.m. CEST. All documents relating to this meeting are now available on www.solvay.com.

Main agenda topics submitted to shareholders’ approval

Shareholders will be asked to vote on a number of resolutions, including the approval of the financial statements for the financial year 2021, the discharge to be given to the directors and the statutory auditor, the remuneration report and the new remuneration policy.

The Board will also propose to approve a total gross dividend of €3.85 per share. 2021 marks another year of significant progress in Solvay’s transformation journey, achieving its G.R.O.W. strategic targets three years ahead of plan, with 4% annual EBITDA growth since 2019, a Free Cash Flow conversion ratio over 30% and a 11% ROCE level. The company today is stronger on all fronts, reaching record levels in EBITDA, net profit and returns, while overcoming significant increases in raw material and energy costs.

Shareholders will also be asked to approve changes to the Board of Directors, including the appointment of two new independent director nominees, Ms. Laurence Debroux and Mr. Pierre Gurdjian for a four year term. The additions of Ms. Debroux and Mr. Gurdjian will strengthen the Board’s financial and governance expertise while enhancing the diversity of the Board.

Ms. Debroux brings to the Solvay Board significant CFO and senior executive experience at several listed companies including Heineken, JCDecaux and Sanofi, as well as her deep knowledge of finance, IT, strategy and business development. Ms. Debroux currently serves as a board member of Novo Nordisk, Exor N.V. and of Juventus Football Club S.p.A.

Mr. Gurdjian brings unique experience as a Senior Partner at McKinsey & Company as well as his deep knowledge of governance, and corporate social responsibility. He is a co-founder of Belgium’s 40 under 40, an initiative fostering a new generation of young societal leaders. He is also President of the Board of the Free University of Brussels (ULB) and a member of the board of UCB and Lhoist.

In reference to the current Board mandates, Mr Gilles Michel and Mr. Matti Lievonen will be proposed for renewal of a four-year term. Ms. Rosemary Thorne will be proposed for renewal of a one year term to ensure the smooth transition of her Board duties, particularly her role as Chair of the Audit Committee. Mr. Philippe Tournay has decided not to renew his mandate and will step down from the Board.

Nicolas Boël, Chairman of Solvay’s Board of Directors commented, “On behalf of the Board of Directors, I would like to thank Mr. Philippe Tournay for his significant contributions. We are pleased to propose the appointment of Ms. Laurence Debroux and Mr. Pierre Gurdjian and are confident that their experiences will further enhance the Board’s effectiveness at the service of Solvay’s continued future development.”

Shareholders will also be asked to vote for the appointment of Ernst & Young as new statutory auditor since the mandate of Deloitte expires at the end of this general meeting.

Meeting information

The meeting will take place at 10:30 CEST, at the Square Brussels Meeting Center, Mont des Arts B-1000 Brussels.

Only shareholders of Solvay SA who are officially recorded as such on April 26, 2022 at 12.00 p.m. CEST will have the right to participate and vote at the meeting on May 10, irrespective of the number of shares they hold on the day of the meeting.

Shareholders who wish to participate at the meeting, either in person or digitally, should declare their intentions no later than on May 4, 2022 and are required to follow the instructions indicated in the convening notice available on www.solvay.com.

The meeting will be organized in hybrid mode, both in person and digitally. Accordingly, shareholders will be able to attend the meeting physically or to exercise their rights either by granting a proxy or by participating and voting digitally in a live and interactive manner via the Lumi's AGM+ platform (https://lumiagm.com/). Additional details are available in the convening notice available on www.solvay.com.

Although the digital platform enables live interaction, shareholders are strongly encouraged to submit their questions in writing prior to the meeting, as this will help to ensure that answers provided at the meetings are as comprehensive and pertinent as possible. All questions can be addressed to ag.solvay@solvay.com by May 4, 2022 the latest.

Visit the Shareholders’ Meeting dedicated page for more details regarding the agenda, the admission conditions and voting methods.

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction to Company announcement – No. 23 / 202419.4.2024 22:20:51 CEST | Press release

Correction to Company announcement – No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has a correction to company announcement No. 23 /2024, April 19, 2024 - regarding transactions in Zealand’s shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons it was reported that member of the management, Henriette Wennicke, was allocated a total of 8,008 restricted stock units with a total value of DKK 9,577,568.00. The correct number was a total of 8,008 restricted stock units with a total value of DKK 4,788,784.00. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10

Nokia Corporation: Repurchase of own shares on 19.04.202419.4.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 19 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 19.04.2024 Espoo, Finland – On 19 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL430,8933.30CEUX--BATE--AQEU--TQEX--Total430,8933.30 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of

Landsbankinn hf.: Results of the 2024 AGM of Landsbankinn19.4.2024 20:48:08 CEST | Press release

The annual general meeting (AGM) of Landsbankinn, held on 19 April 2024, agreed to pay a dividend amounting to ISK 16,535 million to shareholders. The dividend is equivalent to 50% of 2023 profits. The dividend will be paid in two instalments, firstly on 24 April 2024 and secondly on 16 October 2024. As a result, total dividend paid by the Bank in 2013-2024 amounts to ISK 191.7 billion. At the AGM, held in Reykjastræti 6, Helga Björk Eiríksdóttir, Chairman of the Board of Directors, delivered the report from the Board for 2023. Lilja Björk Einarsdóttir, CEO, spoke of the Bank’s operation, strategy and activities in the past operating year. The annual financial statement for the past operating year was approved, as was the proposed Remuneration Policy and remuneration to Directors of the Board. The AGM elected the Auditor General (Ríkisendurskoðun) as auditor of Landsbankinn hf. for the 2024 operating year. The Auditor General, in accordance with an authorisation to outsource tasks, and

SKEL fjárfestingafélag hf.: Styrkás finalizes the purchase of Stólpi Gámar ehf. and affiliated companies.19.4.2024 19:20:57 CEST | Press release

Reference is made to the announcement dated 31 January 2024, regarding Styrkás hf., a company 69.64% owned by SKEL fjárfestingafélag hf., signing a purchase agreement to acquire 100% of the shares in six subsidiaries of Máttarstólpi ehf. The purchase agreement was subject to the approval of the Competition Authority. The transaction was finalized today with payment of purchase price and delivering of shares in the following companies: - Stólpi Gámar ehf., id. 460121-1590, Klettagörðum 5, 104 Reykjavík: - Stólpi Smiðja ehf., id. 460121-1750, Klettagörðum 5, 104 Reykjavík; - Klettskjól ehf., id. 460121-0510, Klettagörðum 5, 104 Reykjavík; - Stólpi ehf., 460121-0430, Klettagörðum 5, 104 Reykjavík; - Tjónaþjónustan ehf., id. 460121-1670, Klettagörðum 5, 104 Reykjavík; - Alkul ehf., id. 491020-0830, Haukdælabraut 48, 113 Reykjavík. collectively referred to as "the sold companies". These companies will continue to be operated on a consolidated basis. The Enterprise value of the sold companie

HiddenA line styled icon from Orion Icon Library.Eye